Table: Hisamitsu -2020/21 parent results
Apr 8 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2021 Feb 29, 2020 Feb 28, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 86.69 109.76
(-21.0 pct) (+0.5 pct)
Operating 9.44 20.31
(-53.5 pct) (+14.2 pct)
Recurring 10.37 21.50
(-51.8 pct) (+8.0 pct)
Net 8.34 15.07
(-44.7 pct) (-5.5 pct)
EPS 102.07 yen 183.45 yen
EPS Diluted 101.97 yen 183.23 yen
Ann Div 83.50 yen 83.00 yen 84.00 yen
-Q2 Div 41.75 yen 41.50 yen 42.00 yen
-Q4 Div 41.75 yen 41.50 yen 42.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO